ULTRAGENYX EUROPE GMBH
502078-5456ActiveAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Oversikt
- 1–4
- Ansatte
- Ukjent
- Omsetning
- 2022
- Grunnlagt
Nøkkelbeslutningstakere
Emil D. Kakkis
Chief Executive Officer and President
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President
Beskrivelse
Ultragenyx is a dedicated biopharmaceutical company focused on transforming the lives of individuals living with rare and ultra-rare genetic diseases. The organization commits itself daily to the development and delivery of novel treatments where none currently exist. They achieve this by exploring...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- Utländsk juridisk person
- MVA-nummer
- SE502078545601
Beslutningstakere
2 kontakter i FunnelfeedrEmil D. Kakkis
Chief Executive Officer and President
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrBridgeBio International GmbH
1–4 ansatteDeveloping transformative medicines for rare genetic conditions quickly.
SAREPTA THERAPEUTICS, INC.
0 ansatteEngineering precision genetic medicine to rescue lives from rare diseases.
OxThera Intellectual Property AB
0 ansatteDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Orchard Therapeutics (Sweden) AB
1–4 ansatteDeveloping life-transforming HSC gene therapies for severe genetic diseases.
AMICUS THERAPEUTICS LTD
1–4 ansatteGlobal biotechnology company developing transformative medicines for rare diseases.
Utforsk mer
Spørsmål om ULTRAGENYX EUROPE GMBH
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo